NEXGEL, Inc. (NXGL) Stock Analysis & Investment Frameworks
NEXGEL, Inc. (NXGL) stock analysis on Invetso. Review NEXGEL, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
NEXGEL, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
NEXGEL, Inc. Key Financial Metrics
- Market Cap: $100860.00
- Revenue: $11.42M
- ROE: -133.10%
- ROIC: -41.80%
- Dividend Yield: N/A
About NEXGEL, Inc.
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
NEXGEL, Inc. Investment Frameworks
Invetso analyzes NEXGEL, Inc. (NXGL) across the following frameworks:
- NEXGEL, Inc. 10Y Growth Potential
- NEXGEL, Inc. Scenario Analysis
- NEXGEL, Inc. Risks & Opportunities
- NEXGEL, Inc. Economic Moat
- NEXGEL, Inc. Business Model
- NEXGEL, Inc. Management
- NEXGEL, Inc. SWOT Analysis
- NEXGEL, Inc. Porter's 5 Forces
- NEXGEL, Inc. PESTLE Analysis
- NEXGEL, Inc. ESG Analysis